Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Radiogenomics in lung cancer: Where are we?

Lung cancer (Amsterdam, Netherlands) - 1 Feb 2023

Aguado-Barrera Miguel E, Sosa-Fajardo Paloma, Gómez-Caamaño Antonio, Taboada-Valladares Begoña, Couñago Felipe, López-Guerra José Luis, Vega Ana

Abstract excerpt

Huge technological and biomedical advances have improved the survival and quality of life of lung cancer patients treated with radiotherapy. However, during treatment planning, a probability that the patient will experience adverse effects is assumed. Radiotoxicity is a complex entity that is largely dose-dependent but also has important intrinsic factors. One of the most studied is the genetic variants that may...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Neoplasms
Share to Polymorphism, Single Nucleotide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Quality of Life

Share to Radiation Injuries

Share to Radiation Tolerance

Source

Identifiers

PMID: 36621035
DOI: 10.1016/j.lungcan.2023.01.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Radiogenomics in lung cancer: Where are we?PMID 36621035Read ↗

Predictive SNPs for radiation-induced damage in lung cancer patients with radiotherapy: a potential strategy to individualize treatment.Semantic proximity Read ↗

Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung CancerSemantic proximity Read ↗

Radiogenomics - current status, challenges and future directions.Semantic proximity Read ↗

Radiogenomics: the search for genetic predictors of radiotherapy response.Semantic proximity Read ↗

Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.Semantic proximity Read ↗

Genetics and genomics of radiotherapy toxicity: towards predictionSemantic proximity Read ↗

Radiomics/Radiogenomics in Lung Cancer: Basic Principles and Initial Clinical ResultsSemantic proximity Read ↗

Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment.Semantic proximity Read ↗

Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer.Semantic proximity Read ↗

Genomic determinants of normal tissue toxicity after radiotherapy for head and neck malignancy: a systematic review.Semantic proximity Read ↗

The molecular epidemiology of lung cancer.Semantic proximity Read ↗

Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.